BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Medigus 

Omer Industrial Park
Building 7A
P.O. Box 3030

Omer    3030  Israel
Phone: 972-8-6466-880 Fax: 972-8-6466-770


SEARCH JOBS


Industry
Medical Device






 Company News
Study Presented At SAGES 2014 Shows Anterior Fundoplication With Medigus (MDGS.TA)' MUSE™ System Can Reduce GERD Patients' Use Of Ppis 4/7/2014 8:49:16 AM    More...
Medigus (MDGS.TA) Gets FDA Clearance For MUSE System 3/24/2014 9:59:53 AM    More...
Medigus (MDGS.TA) To Present Its Commercial Strategy At The 26th Annual Roth Conference 2/25/2014 6:25:46 AM    More...
Medigus (MDGS.TA) To Present Its Unique SRS™ Technology At The Needham Growth Conference On January 15, 2014 1/8/2014 6:15:01 AM    More...
Medigus (MDGS.TA) Raises Approximately $7 Million From U.S and Israeli Investors 10/22/2013 7:13:37 AM    More...
Medigus (MDGS.TA) Announces Marketing Approval From the Israeli Ministry of Health (MEA) for SRS™ System for the Treatment of Gastroesophageal Reflux Disease (GERD) 9/12/2013 9:25:03 AM    More...
Medigus (MDGS.TA)' Board Approves Christopher Rowland as New CEO 8/13/2013 7:08:15 AM    More...
Medigus: Successful Three-Year Follow-Up Data of the SRS(TM) Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando 5/16/2013 9:57:50 AM    More...
Medigus Announces $8 Million Private Placement to OrbiMed 3/14/2013 7:11:45 AM    More...
Medigus' SRS Endoscopic System Receives FDA Clearance for Treatment of Gastroesophageal Reflux Disease (GERD) 5/24/2012 8:08:06 AM    More...
12

//-->